$59.65+9.95% · 3M
Moving avg
1W+6.67%
1M+4.59%
3M+9.95%
6M+7.77%
YTD+28.39%
1Y+98.83%
3Y+29.67%
5Y+123.74%
52-week range
$29.0885% of range$65.00
Company health
Value1/6
Growth0/6
Profitability0/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 49% upside to a $89 target
- Analyst consensus is "Buy"
Risks
- Burning free cash flow
Key statistics
Valuation
Market cap
$8.61B
Enterprise value
$7.89B
P/E ratio (TTM)
-8.08x
P/S ratio (TTM)
0.00x
EV/EBITDA
-8.57x
Per share & returns
EPS (TTM)
-$6.78
Dividend yield
0.00%
Beta (1Y)
1.22
30-day change
+4.59%
Trading
Volume (24h)
1.21M
Previous close
$59.22
Shares outstanding
144.40M
About Vaxcyte, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
PCVX
Vaxcyte, Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker PCVX.
Frequently asked questions
What is Vaxcyte, Inc.'s market cap?
Vaxcyte, Inc. (PCVX) has a market capitalization of $8.61B.
What sector is Vaxcyte, Inc. in?
Vaxcyte, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does PCVX trade on?
PCVX trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.40-0.57%
$355.88B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.72-0.39%
$289.31B cap
AstraZeneca PLCLON: AZN
£116.32-0.60%
$243.20B cap